Drug prices increased twice as quickly than expected during shortage

Credit: CC0 Public Domain

Prices for drugs under shortage between 2015 and 2016 increased more than twice as quickly as they were expected to in the absence of a shortage. While researchers could not assess reasons for the increases, manufacturers were suspected of exploiting shortages to charge more for drugs in high demand. A brief research report is published in Annals of Internal Medicine.

Prescription drug shortages cause an estimated $230 million in additional each year because of the rising of drugs under shortage and the higher costs of substitution drugs. This public health crisis may require attention from policymakers.

Researchers from the University of Pittsburgh School of Pharmacy, UPMC Health Plan and Harvard Medical School used the U.S. Food and Drug Administration (FDA) drug shortages database to identify an active shortage of 917 drugs between December 2015 and December 2016. They then used pricing data from AnalySource to extract monthly wholesale acquisition costs for each in the month of the shortage began and the 12 months before and after. In the 11 months after the shortage began, the expected price increase for all drugs was 20 percent compared with 9 percent in the absence of a shortage. The researchers speculate that price increases reflect manufacturers' opportunistic behavior during shortages, when the imbalance between supply and demand increases willingness to pay.

More information: http://annals.org/aim/article/doi/10.7326/M18-1137Annals of Internal Medicine (2018).

Journal information: Annals of Internal Medicine
Citation: Drug prices increased twice as quickly than expected during shortage (2018, September 18) retrieved 13 July 2024 from https://medicalxpress.com/news/2018-09-drug-prices-quickly-shortage.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA launches first app to identify drug shortages


Feedback to editors